MAPS (Multidisciplinary Association for Psychedelic Studies) is a leading non-profit organization founded in 1986. Our mission is to conduct research and provide education on the beneficial and responsible use of psychedelics and marijuana for mental health and well-being. With a focus on medical, legal, and cultural shifts, we aim to change the way people perceive and engage with these substances.

Over the past 36 years, we have been at the forefront of groundbreaking research, advocating for the therapeutic potential of psychedelics like MDMA, LSD, Marijuana, Ibogaine, and Ayahuasca. MAPS has raised over $130 million for psychedelic research and education, demonstrating our commitment to advancing the field. Our achievements include publishing the results from the first study on LSD therapy in over 40 years and organizing Psychedelic Science conferences that bring together international researchers.

We are dedicated to diversity and inclusivity, providing equal employment opportunities and working towards decriminalization and regulation of all drugs. Join us in this movement for radical healing and access to psychedelic research and education for everyone